Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial
- Ravassa, S.
- Trippel, T.
- Bach, D.
- Bachran, D.
- González, A.
- López, B.
- Wachter, R.
- Hasenfuss, G.
- Delles, C.
- Dominiczak, A.F.
- Pieske, B.
- Díez, J.
- Edelmann, F.
ISSN: 1879-0844, 1388-9842
Année de publication: 2018
Volumen: 20
Número: 9
Pages: 1290-1299
Type: Article
